Provided by Tiger Trade Technology Pte. Ltd.

JENSCARE-B

7.490
-0.010-0.13%
Volume:2K
Turnover:14.89K
Market Cap:3.12B
PE:-10.03
High:7.490
Open:7.490
Low:7.400
Close:7.500
52wk High:11.980
52wk Low:6.000
Shares:417.17M
HK Float Shares:310.31M
Volume Ratio:0.71
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.747
ROE:-32.27%
ROA:-15.04%
PB:3.39
PE(LYR):-10.03
PS:29.56

Loading ...

Jenscare Scientific Sets 31 Aug 2026 Board Meeting to Approve 1H26 Results and Potential Interim Dividend

Bulletin Express
·
Aug 19

Jenscare Scientific Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 19

Jenscare Scientific Expects Revenue to Jump Up to 400% in H1

MT Newswires Live
·
Aug 10

JENSCARE-B (09877) Forecasts Mid-Year Revenue Surge of 385% to 400%

Stock News
·
Aug 10

Jenscare Scientific Co - Forecasts 2026 Interim Revenue of RMB63 Mln–RMB65 Mln, up 385%-400% Y/Y

THOMSON REUTERS
·
Aug 10

Jenscare Completes First Implants in FDA Pivotal Trial for Lux-valve Plus Tricuspid Valve System

Reuters
·
Jul 16

JENSCARE-B Shares Surge Following EU Regulatory Approval for Key Heart Valve System

Stock News
·
Jul 08

Jenscare Scientific Says Lux-valve Plus Obtains EU MDR CE Certification

Reuters
·
Jul 08

Jenscare Earns EU MDR CE Mark for LuX-Valve Plus, Strengthening Global Expansion of Tricuspid Valve Portfolio

Bulletin Express
·
Jul 08

Jenscare-B's LuX-Valve Plus Transvenous Tricuspid Valve Replacement System Secures EU MDR CE Certification

Stock News
·
Jul 08

Jenscare Says Lux-valve Plus Wins EU MDR CE Certification

Reuters
·
Jul 08

Jenscare Scientific Co - Lux-valve Plus Obtains EU Mdr Ce Certification

THOMSON REUTERS
·
Jul 08

JENSCARE-B Reports No Share Capital Changes in June; Public Float Remains Compliant

Bulletin Express
·
Jul 07

JENSCARE-B's Ken-Valve Transcatheter Aortic Valve System Receives Approval from Hong Kong Department of Health

Stock News
·
Jun 22

Jenscare Scientific - Ken-Valve Transcatheter Aortic Valve Replacement System Receives Approval From Hong Kong Department of Health

THOMSON REUTERS
·
Jun 22

Jenscare says Hong Kong health regulator approves Ken-Valve TAVR system

Reuters
·
Jun 22

Jenscare Scientific clears all resolutions at 2025 AGM; re-appoints Ernst & Young and secures fresh share mandates

Bulletin Express
·
May 28

Jenscare shareholders approve 2025 AGM resolutions

Reuters
·
May 28

JENSCARE-B (09877): 12-Month Clinical Follow-Up Results for Large Annulus Patients in LuX-Valve Plus EU TRINITY Study Presented at EuroPCR 2026, Highlighting Device's Large-Size Capability

Stock News
·
May 21

Jenscare Scientific Maintains Stable Share Capital in April 2026; Public-Float Requirement Met

Bulletin Express
·
May 07